Latest News

Date Title Topic
12 Dec 2019 ESMO Immuno-Oncology Congress 2019
12 Dec 2019 First-line Nivolumab Plus Ipilimumab is Safe and Provides Encouraging Survival in Patients with Advanced NSCLC and Co-Morbidity or Poor Performance Status Lung and other thoracic tumours - Cancer in Special Situations / Population - Cancer Immunology and Immunotherapy
12 Dec 2019 Pembrolizumab May Be Considered as a First-Line Treatment Option in Non-Squamous NSCLC Even in the Presence of KRAS Mutations Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
12 Dec 2019 Early Introduction of Corticosteroids May Alter the Efficacy of Immune Checkpoint Inhibitors Lung and other thoracic tumours - Genitourinary cancers - Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
11 Dec 2019 A Daratumumab-Based Combination Shows a Significant Improvement in Overall Survival in Newly Diagnosed Multiple Myeloma Haematologic malignancies - Anticancer agents & Biologic therapy
10 Dec 2019 ESMO Immuno-Oncology Congress 2019
10 Dec 2019 Patient Guide on Survivorship Now Available in Finnish
09 Dec 2019 FDA Approves Atezolizumab With Nab-paclitaxel and Carboplatin for Metastatic Non-squamous NSCLC Without EGFR/ALK Aberrations Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
06 Dec 2019 Cervical Cancer Ranked in the Top Three Cancers Affecting Women Younger Than 45 Years Gynaecologic malignancies - Epidemiology/Etiology/Cancer Prevention
05 Dec 2019 FDA Approves Crizanlizumab-tmca and Voxelotor for Sickle Cell Disease Haematologic malignancies
04 Dec 2019 Weekly Dose-Dense Chemotherapy Does Not Improve PFS in First-Line Treatment for Epithelial Ovarian Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
02 Dec 2019 ESMO Immuno-Oncology Congress 2019: From the Basics of Immunotherapies to the Latest Research Results [ESMO Media Alert] Cancer Immunology and Immunotherapy
02 Dec 2019 People with Mental Illness Receive Less Cancer Screening Cancer in Special Situations / Population - Epidemiology/Etiology/Cancer Prevention
29 Nov 2019 Randomised Trial of Supplemental MRI Screening in Women with Extremely Dense Breast Tissue Breast cancer - Epidemiology/Etiology/Cancer Prevention
28 Nov 2019 EMA Recommends Granting a Conditional Marketing Authorisation for Polatuzumab Vedotin Haematologic malignancies - Anticancer agents & Biologic therapy